STAT
SEPTEMBER 20, 2024
A second health worker who cared for a person hospitalized in Missouri with H5N1 bird flu developed mild respiratory symptoms but was not tested for influenza, the Centers for Disease Control and Prevention reported on Friday. The CDC said Missouri health officials didn’t learn that the health worker had symptoms until after the individual had recovered, too late to run a diagnostic test.
PharmaVoice
SEPTEMBER 16, 2024
Five ways to beat study timeline pressures and get medicines to patients faster.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ALiEM - Pharm Pearls
SEPTEMBER 20, 2024
A 50-year-old male with insulin-dependent Type 2 Diabetes presented to the emergency department with three days of pain and swelling on the right side of his neck. He endorsed progression of his symptoms, reporting that he was now having fevers, myalgias, and intermittent difficulty swallowing solid foods. Additional Images Physical Exam Vitals : BP 153/96; HR 110; T 100.0°F; RR 16; O2 sat 97% General : Appears uncomfortable HEENT : Mild right-sided facial swelling.
vizient
SEPTEMBER 18, 2024
The awards recognize the achievements of participating hospitals and health systems in patient care quality and supply chain excellence and were announced Sept. 17 in Las Vegas.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
SEPTEMBER 20, 2024
The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that “artificially inflated” the price of insulin and, consequently, impeded patient access to the life-saving treatment. The administrative complaint accused CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx of creating a “perverse” system of rebates that favored
PharmaVoice
SEPTEMBER 18, 2024
Overpromising, overcommitting and neglecting CMC are a few of the pitfalls that cause sponsors to stumble when submitting a new drug application.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
SEPTEMBER 19, 2024
National Pharmacy Association (NPA) members across the UK have participated in a second day of action today by wearing black, displaying posters and raising awareness of the impact of funding cuts on the sector. It comes as the NPA has announced plans to escalate its action and ballot its members on 'working to rule'. Gordons […] The post Protest action hoped to spotlight pharmacy plight appeared first on The Pharmacist.
STAT
SEPTEMBER 20, 2024
The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration. Starting next flu season, people who want to order the vaccine to give it to themselves or their children at home will be able to do so.
PharmaVoice
SEPTEMBER 19, 2024
The disparate teams of research and commercial at J&J work closely together from the get-go.
Pharma Times
SEPTEMBER 18, 2024
It is hoped that the tool will improve the diagnostic pathway and free up radiologists’ time
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The Pharmacist
SEPTEMBER 20, 2024
The Pharmacist has launched a new and exclusive survey to gather opinions from community pharmacists, general practice pharmacists, and pharmacy contractors and owners in the UK. Our 2024 survey will cover a range of topics including, pharmacy closures, workload, recruitment, training, medicines shortages, independent prescribing and more. Take the survey here Depending on your job role, it […] The post Take our 2024 survey and potentially win £100 worth of vouchers appeared first on The P
STAT
SEPTEMBER 19, 2024
GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease , addiction , and even Alzheimer’s. Now, three scientists who played key roles in their invention have won a prestigious Lasker Award for biomedical research. Announced on Thursday in New York, the Lasker-DeBakey Clinical Medical Research Award will be shared by Svetlana Mojsov and Joel Habener , who identified and characterized the GLP-1 hormone in the 1980s whil
PharmaVoice
SEPTEMBER 17, 2024
Big Pharma is embracing the radiopharmaceuticals boom that was a long time in the making.
BioPharma Dive
SEPTEMBER 19, 2024
Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The Pharmacist
SEPTEMBER 17, 2024
Joanna Robertson reports on an exclusive roundtable, held in August this year, which brought together community pharmacy and general practice representatives to discuss the successes, challenges and future of Pharmacy First, six months after the service began in England. Pharmacy First launched in England on 31 January 2024, and sees pharmacists funded to provide advice […] The post Roundtable: Six months of Pharmacy First appeared first on The Pharmacist.
STAT
SEPTEMBER 18, 2024
At the recent annual International AIDS Conference, a startling presentation about the newest wonder drug in HIV prevention brought a raucous standing ovation. Lenacapavir, a novel drug given as an injection under the skin every six months, was 100% successful in preventing HIV in adolescent girls and young women in two countries in Africa. It felt to many like a generational moment.
PharmaVoice
SEPTEMBER 16, 2024
After the House of Representatives passed the Biosecure Act last week, U.S. biotechs could be forced to cut ties with five Chinese contract partners.
Pharma Times
SEPTEMBER 16, 2024
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
SEPTEMBER 18, 2024
The General Pharmaceutical Council (GPhC) has proposed new guidance to safeguard against the risks of online prescribing, including of weight loss medication. This follows 'significant risks to patient safety when online questionnaires have inappropriately been the only mode of consultation used', which the GPhC said it had observed through its inspections and investigations.
STAT
SEPTEMBER 18, 2024
Last year, a Springer Nature journal published a study surveying 1,700 parents of adolescents and young adults with gender dysphoria. Just a few months later, the study was retracted because there had been no formal process for those parents to consent to the study. But the story didn’t end there. Ongoing fallout from the paper and its retraction has opened up an internal rift among academic editors and journal staff that led to one editor’s resignation, as first reported by Retrac
PharmaVoice
SEPTEMBER 18, 2024
The FDA’s backlog of overseas drug manufacturer inspections is still mounting — and new drugs could be delayed as a result.
BioPharma Dive
SEPTEMBER 15, 2024
Final follow-up results suggest Opdivo and Yervoy could be close to a cure for some people with advanced melanoma, shifting how doctors administer follow-up care.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
SEPTEMBER 19, 2024
Community Pharmacy England (CPE) has suggested that the outcome of the National Pharmacy Association (NPA)'s ballot could inform considerations around its own negotiating tactics and positioning. Pharmacy sector leaders have today joined the NPA to deliver a petition to Downing Street and to voice concerns about pharmacy funding, following the membership organisation's announcement that it […] The post Negotiator 'interested' to hear outcome of NPA ballot appeared first on The Ph
STAT
SEPTEMBER 16, 2024
More work needs to be done by the agricultural sector to get to the bottom of — and put a stop to — transmission of H5N1 bird flu in dairy cattle in the United States, a senior World Health Organization official said over the weekend. Maria Van Kerkhove, the WHO’s acting director of epidemic and pandemic preparedness and prevention, said the world is watching how the U.S., with its advanced scientific expertise, is responding to this outbreak.
PharmaVoice
SEPTEMBER 16, 2024
Treatments for glioblastoma have fallen short in the face of difficult challenges, but the pipeline is full of renewed attempts.
pharmaphorum
SEPTEMBER 18, 2024
PBM Express Scripts has sued the FTC, claiming its recent report on the sector's role in drug pricing is defamatory and should be retracted
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
SEPTEMBER 17, 2024
The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' case, however.
STAT
SEPTEMBER 16, 2024
To address soaring rates of childhood obesity, the American Academy of Pediatrics last year endorsed tactics it once considered risky. “Watchful waiting” had been standard practice, in part from concern that a doctor’s focus on weight could inadvertently plant the seed for stigma or eating disorders like anorexia and bulimia.
PharmaVoice
SEPTEMBER 20, 2024
Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.
Pharma Times
SEPTEMBER 17, 2024
The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension
BioPharma Dive
SEPTEMBER 17, 2024
The funding will support mid-stage testing of a drug the company believes to have the potential to treat a range of neurodegenerative conditions.
Expert insights. Personalized for you.
364 
Let's personalize your content